Some key points from The White House daily email:
====================================================
The White House • March 19, 2020
Medical breakthroughs are too often held back by outdated, burdensome government rules and regulations.
As America faces an unprecedented global threat from the Coronavirus, President Trump made another important announcement at today’s White House briefing.
“Today I want to share with you exciting progress that the FDA is making with the private sector as we slash red tape like nobody has ever done it before,” he said. “I’ve directed the FDA to eliminate outdated rules and bureaucracy so this work can proceed rapidly, quickly—and, I mean, fast. And we have to remove every barrier.”
The FDA is committed to providing regulatory flexibility and guidance during this crisis, while fulfilling its duty to ensure product safety and effectiveness, FDA Commissioner Dr. Stephen Hahn said during today’s briefing.
As a result, obstacles are being cleared for American patients with incredible speed. That includes not only the race to develop a vaccine, but progress in making antiviral therapies widely available. Clinical trials for therapies to fight the Coronavirus are already underway, as well.
“One thing I know about this country of ours is that we have unbelievable innovators. We have people who every day, it’s their job to develop treatments for all sorts of diseases,” Dr. Hahn said.
New research shows they may hold unique promise as potentially effective treatments for Coronavirus, too.
====================================================
The White House • March 19, 2020
Medical breakthroughs are too often held back by outdated, burdensome government rules and regulations.
As America faces an unprecedented global threat from the Coronavirus, President Trump made another important announcement at today’s White House briefing.
“Today I want to share with you exciting progress that the FDA is making with the private sector as we slash red tape like nobody has ever done it before,” he said. “I’ve directed the FDA to eliminate outdated rules and bureaucracy so this work can proceed rapidly, quickly—and, I mean, fast. And we have to remove every barrier.”
The FDA is committed to providing regulatory flexibility and guidance during this crisis, while fulfilling its duty to ensure product safety and effectiveness, FDA Commissioner Dr. Stephen Hahn said during today’s briefing.
As a result, obstacles are being cleared for American patients with incredible speed. That includes not only the race to develop a vaccine, but progress in making antiviral therapies widely available. Clinical trials for therapies to fight the Coronavirus are already underway, as well.
“One thing I know about this country of ours is that we have unbelievable innovators. We have people who every day, it’s their job to develop treatments for all sorts of diseases,” Dr. Hahn said.
New research shows they may hold unique promise as potentially effective treatments for Coronavirus, too.
9
